Evidence map›Paper›PMID 34012266›Full record

ArticleNeuropsychiatric disease and treatment2021

Efficacy and Safety of tDCS and tACS in Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Factorial Placebo-Controlled Study Design.

Yuxin Huang, Linjie Shen, Jia Huang, Xianrong Xu, Yong Wang, Hua Jin

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yuxin HuangDepartment of Outpatient, Shanghai Mental Health Center, Shanghai, People's Republic of China.
Linjie ShenDepartment of Outpatient, Shanghai Mental Health Center, Shanghai, People's Republic of China.ORCID 0000-0002-1718-5297
Jia HuangDepartment of Outpatient, Shanghai Mental Health Center, Shanghai, People's Republic of China.
Xianrong XuSchool of Public Health, Hangzhou Normal University, Hnagzhou, Zhejiang Province, People's Republic of China.
Yong WangDepartment of Outpatient, Shanghai Mental Health Center, Shanghai, People's Republic of China.
Hua JinDepartment of Outpatient, Shanghai Mental Health Center, Shanghai, People's Republic of China.
Shanghai Mental Health Center · CNHangzhou Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranscranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) are regarded as promising antidepressant treatments.

objectiveTo compare the efficacy and safety of tDCS, tACS, escitalopram, and placebo/sham stimulation controls.

designRandomized, parallel, double-blind, placebo-controlled study.

methodsSample sizes were calculated based on data from previous similar studies. Eligible non-treatment-resistant-depressive outpatient subjects with moderate-to-severe depression (HRDS ≥17) are randomized to receive (1) tDCS + placebo; (2) tACS + placebo; (3) escitalopram + placebo; or (4) sham stimulation + placebo. The intensity of electricity is 2 mA, lasting for 30 minutes over two consecutive working days (10 sessions in total). The medication lasts for 6 weeks. The primary outcome measure was the response rates within 6 weeks (week 6 is also the endpoint of the study), and secondary outcome measures included changes in other clinical measurements. Safety and acceptability are measured by adverse event rates and dropout rates. Exploring outcome consist of the performance of cognitive battery as well as neurophysiology results.

conclusionTo the best of our knowledge, the present study is the first double-blind controlled study comparing tDCS, tACS, and clinically used antidepressants, which will provide further evidence for their efficacy and safety in possible clinical applications.

Indexed as

electrical stimulationmajor depressive disorderMDDtACStDCStranscranial alternating current stimulationtranscranial direct current stimulation

Identifiers

PMID34012266
PMCPMC8128494
OpenAlexW3163333631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.